Clinical Trial Update: Safety and Efficacy Study of PRI-724 in Subjects With Advanced Myeloid Malignancies [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 study of PRI-724 in adults with advanced myeloid malignancies (acute and chronic myeloid leukemia) evaluated safety and preliminary effica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia

Drugs mentioned

• PRI-724 (PRI-724)

Snippet

Sponsor: Prism Pharma Co., Ltd. | Conditions: Acute Myeloid Leukemia, Chronic Myeloid Leukemia | Phase 1, Phase 2 | Status: COMPLETED